Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands : insights from the ETNA-AF-Europe study

Abstract: Background: Studies on the use of non-vitamin K antagonist oral anticoagulants in unselected patients with atrial fibrillation (AF) show that clinical characteristics and dosing practices differ per region, but lack data on edoxaban. Methods: With data from Edoxaban Treatment in routiNe clinical prActice for patients with AF in Europe (ETNA-AF-Europe), a large prospective observational study, we compared clinical characteristics (including the dose reduction criteria for edoxaban: creatinine clearance 15-50 mL/min, weight <= 60 kg, and/or use of strong p-glycoprotein inhibitors) o... Mehr ...